News
QDEL
43.77
+0.74%
0.32
Weekly Report: what happened at QDEL last week (0923-0927)?
Weekly Report · 6d ago
Weekly Report: what happened at QDEL last week (0916-0920)?
Weekly Report · 09/23 09:22
Cracking The Code: Understanding Analyst Reviews For QuidelOrtho
Benzinga · 09/19 21:01
QuidelOrtho Price Target Raised to $50.00/Share From $42.00 by UBS
Dow Jones · 09/19 19:14
QuidelOrtho Raised to Neutral From Sell by UBS
Dow Jones · 09/19 19:14
UBS Upgrades QuidelOrtho to Neutral, Raises Price Target to $50
Benzinga · 09/19 19:04
QUIDELORTHO CORP <QDEL.O>: UBS RAISES TARGET PRICE TO $50 FROM $42
Reuters · 09/19 14:30
U.S. RESEARCH ROUNDUP-Athira Pharma, Lowe's Companies, P&G
Reuters · 09/19 07:26
Quidel: Statement of changes in beneficial ownership of securities
Press release · 09/17 22:24
Weekly Report: what happened at QDEL last week (0909-0913)?
Weekly Report · 09/16 09:20
QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt
Simply Wall St · 09/15 13:52
U.S. RESEARCH ROUNDUP-Constellation Energy, Eli Lilly, Talen Energy
Reuters · 09/13 07:51
QUIDELORTHO APPOINTS LEE BOWMAN AS CHIEF HUMAN RESOURCES OFFICER
Reuters · 09/10 11:00
Weekly Report: what happened at QDEL last week (0902-0906)?
Weekly Report · 09/09 09:22
Why QuidelOrtho Stock Blasted 10% Higher Today
The Motley Fool · 09/05 21:25
G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday
Benzinga · 09/05 17:44
QuidelOrtho Price Target Raised to $57.00/Share From $40.00 by Craig-Hallum
Dow Jones · 09/05 16:43
QuidelOrtho Raised to Buy From Hold by Craig-Hallum
Dow Jones · 09/05 16:43
Craig-Hallum Upgrades QuidelOrtho to Buy, Raises Price Target to $57
Benzinga · 09/05 16:32
More
Webull provides a variety of real-time QDEL stock news. You can receive the latest news about Quidel through multiple platforms. This information may help you make smarter investment decisions.
About QDEL
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.